Veledimex (INXN-1001) is an orally active synthetic analog of the insect molting hormone ecdysone, used as an activator ligand in a proprietary gene therapy promoter system; it activates specific genes through the ecdysone receptor (EcR)-based RheoSwitch Therapeutic System (RTS); it is capable of crossing the blood-brain barrier (BBB) in orthotopic GL-261 mouse and cynomolgus monkey models.